Skip to content
Biodatica
Start free

IMPLENOMICS LLCS

MARBLEHEAD, MA

OncologyPhase I
Compare Sign in to watch

What changed

Phase I trial registered: Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

8w agoTrial registeredMay 20, 2026Source filing (opens the source filing in a new tab)

Momentum

76no change

Momentum 76 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    UM1 · $898k · non-dilutive

    Dec 19, 2025

    GEORGE WASHINGTON UNIVERSITY · PI BETHONY, JEFFREY MICHAEL · NCI · award ends Aug 31, 2026 · AIDS and Cancer Specimen Resource (ACSR)

    NIH RePORTER · NIH RePORTER 11468152 (opens the source filing in a new tab)

  2. Grant

    R01 · $70k · non-dilutive

    Sep 19, 2023

    UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIN, LILIE LEMING · NCI · award ends Aug 31, 2028 · The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia

    NIH RePORTER · NIH RePORTER 11412344 (opens the source filing in a new tab)

  3. Grant

    U01 · $751k · non-dilutive

    Sep 1, 2023

    IMPLENOMICS LLCS · PI SUBRAMANIAN, SUJHA · NCI · award ends Aug 31, 2027 · Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia

    NIH RePORTER · NIH RePORTER 11174224 (opens the source filing in a new tab)

  4. Grant

    U01 · $108k · non-dilutive

    Sep 1, 2023

    IMPLENOMICS LLCS · PI SUBRAMANIAN, SUJHA · NCI · award ends Aug 31, 2027 · Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia

    NIH RePORTER · NIH RePORTER 11417071 (opens the source filing in a new tab)

  5. Trial

    PHASE1 registered

    Aug 7, 2020

    Stage II Vulvar Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IIIA Vulvar Cancer AJCC v8, Stage IIIB Vulvar Cancer AJCC v8, Stage IIIC Vulvar Cancer AJCC v8, Stage IVA Vulvar Cancer AJCC v8 · RECRUITING · sponsor: M.D. Anderson Cancer Center · Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

    ClinicalTrials.gov · NCT04169763 (opens the source filing in a new tab)

  6. Grant

    UM1 · $4.0M · non-dilutive

    Sep 23, 2013

    GEORGE WASHINGTON UNIVERSITY · PI BETHONY, JEFFREY MICHAEL · NCI · award ends Aug 31, 2026 · AIDS and Cancer Specimen Resource (ACSR)

    NIH RePORTER · NIH RePORTER 11405860 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources